With our FDA-approved CAR-T cell therapy, we're changing how the world fights cancer.

Proton therapy cyclotron
The Benefits of Proton Therapy

More precise therapy. Less side effects. Better quality of life. Learn more >

Lymphocytes attacking cancer cell
Pioneering Immunotherapy

The FDA recently approved Penn's CAR-T therapy — the first of its kind — for pediatric and young adult leukemia. Read the news release or call 215-316-5127 for more information.

Still of Joe Biden Speaks With Meghan McCain About His Late Son Beau's Battle With Cancer | The View
Joe Biden: "There are breakthroughs"

Former VP Joe Biden consoles Meghan McCain on The View with the promise of Penn's CAR-T cell therapy. Watch now >

US News and World Report Badge
Top Cancer Hospital in the Nation

We are ranked #1 in the Philadelphia region and 7th in the nation for cancer care by U.S. News & World Report.

Clinical Trials Quick Search:

Is CAR-T Therapy Right For Me?

CAR-T is now available to treat adults, ages 18 to 25, with acute lymphoblastic leukemia (ALL). Whether you are newly diagnosed or looking for a second opinion, request a call back and find out if CAR-T is right for you.

Request a Call-Back

We also have CAR T therapy clinical trials available for lymphoma, melanoma, pancreatic cancer, breast cancer, brain cancer and many others.